Carl Ola Landgren: Getting ready with Mohamad Mohty for tomorrow’s opening session at EHA2024

Carl Ola Landgren shared on X:

“Getting ready together with Mohamad Mohty for tomorrow’s opening session at EHA2024 in Madrid, Spain. We will cover the latest news on bispecific monoclonal antibodies in myeloma!”

Source: Carl Ola Landgren/X

Carl Ola Landgren is a Professor of Medicine, Chief of the Myeloma Division at the University of Miami, and a Leader of the Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center.

His clinical and scientific focus has been on the development of novel treatment strategies for patients with myeloma, partnered with molecular profiling (personalized oncology), and developing technologies for minimal residual disease (MRD) assessment.

He has published over 450 peer-reviewed articles in high-impact journals.